106 related articles for article (PubMed ID: 20128976)
1. [Expressions of MDM2 and MMP-7 in normal liver, cirrhosis, hepatocellular carcinoma tissues].
Kang KF; Zhang X; Chen XW
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):67-8. PubMed ID: 20128976
[No Abstract] [Full Text] [Related]
2. [Expression of breast cancer resistance protein in liver cirrhosis, hepatocellular carcinoma and peritumoral tissues].
Wang YM; Huang GS; Hui YP; Zhang J
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):227-9. PubMed ID: 19335991
[No Abstract] [Full Text] [Related]
3. A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis.
Hung TM; Chang SC; Yu WH; Wang YW; Huang C; Lu SC; Lee PH; Chang MF
Hepatology; 2009 Oct; 50(4):1184-93. PubMed ID: 19676133
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of Notch1 in human hepatocellular carcinoma].
Mi LL; Yin F; Du SB; Yao SK
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):628-9. PubMed ID: 23227533
[No Abstract] [Full Text] [Related]
5. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis].
Fu XM; Yang QX; Shao CK; Feng ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):821-3. PubMed ID: 16793609
[TBL] [Abstract][Full Text] [Related]
7. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
8. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
[TBL] [Abstract][Full Text] [Related]
9. [Expression of MCP/CCR2 in patients of hepatocellular carcinoma and liver cirrhosis].
Fang N; Fan X; Zhang XS
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):553-4. PubMed ID: 19912695
[No Abstract] [Full Text] [Related]
10. Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Tretiakova MS; Hart J; Shabani-Rad MT; Zhang J; Gao ZH
Mod Pathol; 2009 Aug; 22(8):1113-20. PubMed ID: 19465902
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of cell cycle and apoptotic proteins in human liver pathologies.
Mitselou A; Karapiperides D; Nesseris I; Vougiouklakis T; Agnantis NJ
Anticancer Res; 2010 Nov; 30(11):4493-501. PubMed ID: 21115898
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
Bedossa P; Peltier E; Terris B; Franco D; Poynard T
Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
14. Selenoprotein P mRNA expression in human hepatic tissues.
Li CL; Nan KJ; Tian T; Sui CG; Liu YF
World J Gastroenterol; 2007 Apr; 13(16):2363-8. PubMed ID: 17511039
[TBL] [Abstract][Full Text] [Related]
15. [Expression and its clinicopathological features of tumor rejective antigen 1 in human tissues of hepatocellular carcinoma and liver cirrhosis].
Zhang H; Huang DF; Wei Q; Hua TY; Li F; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):661-5. PubMed ID: 20943076
[TBL] [Abstract][Full Text] [Related]
16. [The expression of integrin beta 1 in normal hepatic tissues, hepatic cirrhosis tissues and hepatocellular carcinoma].
Zhao G; Cui J; Qin Q; Li SS; Yin T; Chen LB; Wu HS; Wang CY
Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):353-6. PubMed ID: 20510000
[TBL] [Abstract][Full Text] [Related]
17. [Detection of stromelysin mRNA expression in human hepatocellular carcinoma by in situ hybridization].
Fang S; Wu M; Qian Q
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):73-5. PubMed ID: 9206207
[TBL] [Abstract][Full Text] [Related]
18. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
19. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
20. The ether lipid tumour marker in human liver with hepatocellular carcinoma.
Lin HJ; Wu PC; Ho JC
Br J Cancer; 1980 Feb; 41(2):320-4. PubMed ID: 6245673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
